Interventional Clinical Trial in Patients in Overactive Bladder With Nocturia in Women
Condition: Overactive BladderInterventions: Drug: Tolterodine tartrate extended release capsules + Placebo orally disintegrating tablets; Drug: Tolterodine tartrate extended release capsules + Desmopressin orally disintegrating tabletsSponsor: Ferring PharmaceuticalsActive, not recruiting - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bed Wetting | Clinical Trials | Detrol | Enuresis | Overactive Bladder | Overactive Bladder Syndrome | Research | Women